Increased aortic stiffness and blood pressure in non-classic Pompe disease

Journal of Inherited Metabolic Disease

Volumn 37, Issue 3, 2014, Pages 391-397

  Wens, Stephan C A ^a   Kuperus, Esther ^a   Mattace Raso, Francesco U S ^a   Kruijshaar, Michelle E ^a   Brusse, Esther ^a   Van Montfort, Kees C A G M ^a   De Boer, Marjan Scheltens ^a   Sijbrands, Eric J G ^a   Van Der Ploeg, Ans T ^a,b   Van Doorn, Pieter A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCOGEN;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; GOLD STANDARD; GROUPS BY AGE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE PRESSURE; PULSE WAVE; TREATMENT DURATION; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; ENZYME REPLACEMENT; GLYCOGEN STORAGE DISEASE TYPE II; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME REPLACEMENT THERAPY; FEMALE; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84904152445     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9667-2     Document Type: Article

References (30)

1. Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM (1999) The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens 17(12 Pt 2):1831-1835 (Pubitemid 30345318)
2. Braunsdorf WE (1987) Fusiform aneurysm of basilar artery and ectatic internal carotid arteries associated with glycogenosis type 2 (Pompe's disease). Neurosurgery 21(5):748-749
3. Collin C, Briet M, Tran TC et al (2012) Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease. Eur J Prev Cardiol 19(1):43-54
4. DeLoach SS, Townsend RR (2008) Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 3(1):184-192
5. El-Gharbawy AH, Bhat G, Murillo JE et al (2011) Expanding the clinical spectrumof late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered. Mol Genet Metab 103(4):362-366
6. Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S (1998) Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol 31(5):1064-1073 (Pubitemid 28212507)
7. Güngör D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 8(1):49
8. Hirschhorn, R. (2001) Glycogen storage disease type II: acid alpha-glucosidase (Acid Maltase) deficiency. Themetabolic and molecular bases of inherited disease. In: Scriver CR, Sly WS, Valle D, New York, Mc Graw-Hill p3389-3420.
9. Hoeks AP, Brands PJ, Reneman RS (1992) Assessment of the arterial distension waveform using Doppler signal processing. J Hypertens Suppl 10(6):S19-S22
10. Huijben AM, Mattace-Raso FU, Deinum J, Lenders J, van den Meiracker AH (2012) Aortic augmentation index and pulse wave velocity in response to head-up tilting: effect of autonomic failure. J Hypertens 30(2):307-314
11. Kingwell BA, Berry KL, Cameron JD, Jennings GL, Dart AM (1997) Arterial compliance increases after moderate-intensity cycling. Am J Physiol 273(5 Pt 2):H2186-H2191
12. Kobayashi H, Shimada Y, Ikegami M et al (2010) Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab 100(1):14-19
13. Laforet P, Petiot P, Nicolino M et al (2008) Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology 70(22):2063-2066
14. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27(21):2588-2605 (Pubitemid 44627304)
15. Mancia GR, Fagard K, Narkiewicz et al (2013) " 2013 ESH/ESC Guidelines for the management of arterial hypertension." Blood Press.
16. Mattace-Raso FU, van der Cammen TJ, Hofman A et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113(5):657-663
17. Nemes A, Soliman OI, Geleijnse ML et al (2007) Increased aortic stiffness in glycogenosis type 2 (Pompe's disease). Int J Cardiol 120(1):138-141 (Pubitemid 47008992)
18. Nemes A, Timmermans RG, Wilson JH et al (2008) The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness. Heart Vessels 23(2):108-111 (Pubitemid 351494089)
19. Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S (2006) Carotid and aortic stiffness: determinants of discrepancies. Hypertension 47(3):371-376 (Pubitemid 43740277)
20. Sacconi S, Bocquet JD, Chanalet S, Tanant V, Salviati L, Desnuelle C (2010) Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 257(10):1730-1733
21. Soliman OI, van der Beek NA, van Doorn PA et al (2008) Cardiac involvement in adults with Pompe disease. J Intern Med 264(4):333-339
22. Thurberg BL, Lynch Maloney C, Vaccaro C et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86(12):1208-1220 (Pubitemid 44789911)
23. Van Bortel LM, Laurent S, Boutouyrie P et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30(3):445-448
24. van den Hout HM, Hop W, van Diggelen OP et al (2003) The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112(2):332-340 (Pubitemid 36951395)
25. van der Beek NA, de Vries JM, Hagemans ML et al (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 7:88
26. van der Ploeg AT, Reuser AJ (2008) Pompe's disease. Lancet 372(9646):1342-1353
27. van Dijk SC, Smulders YM, Enneman AW et al (2013) Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens 31(5):952-959
28. Verbeke F, Van Biesen W, Honkanen E et al (2011) Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6(1):153-159
29. Winkel LP, Kamphoven JH, van den Hout HJ et al (2003) Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Muscle Nerve 27(6):743-751 (Pubitemid 36667485)
30. Winkel LP, Hagemans ML, van Doorn PA et al (2005) The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 252(8):875-884 (Pubitemid 41186956)